JTCS Concomitant Website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Steven R. Gundry
Norihide Fukushima
Leonard L. Bailey
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gundry, S. R.
Right arrow Articles by Bailey, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gundry, S. R.
Right arrow Articles by Bailey, L. L.

J Thorac Cardiovasc Surg 1995;109:1097-1102
© 1995 Mosby, Inc.


CARDIAC AND PULMONARY REPLACEMENT

Successful survival of primates receiving transplantation with "dead,"nonbeating donor hearts

Steven R. Gundry, MDa, Norihide Fukushima, MDa, Clifford C. Eke, MCa, Arthur C. Hill, MDa, Craig Zuppan, MDb, Leonard L. Bailey, MDa


Loma Linda, Calif.

Address for reprints: Steven R. Gundry, MD, Professor and Head, Divisionof Cardiothoracic Surgery, Department of Surgery, Loma Linda University MedicalCenter, 11234 Anderson St., Loma Linda, CA 92354.

Abstract

A paucity of donor organs is the principal limitationin human heart transplantation. Prompted by our short-term studies of reanimating"dead" donor hearts in sheep, we applied the same reperfusion modificationsin juvenile baboons to determine human applications in an anoxic arrest model(as occurs when non-brain-dead patients are extubated and allowed to die).Ten juvenile baboons (mean weight 3.6 kg) were studied. Five baboons wereused as donors. After being anesthetized, donors were pretreated with methylprednisolone(Solu-Medrol), 50% dextrose, nifedipine, and prostaglandin E1 and then paralyzed and extubated. Donors becamepulseless at 7 ± 1 minutes and had electric arrest 9 to 18 minutesafter paralysis. The five donors were left undisturbed and warm for 15, 22,30, 30, and 31 minutes, respectively, after asystole. They were then given250 ml of 4° C Roe's crystalloid cardioplegic solution via the aorticroot and the hearts were explanted into iced Euro-Collins solution. Five baboonsserved as recipients. After donor harvest, recipients were placed on cardiopulmonarybypass, given prostaglandin E1 , and cooled to 18° C; circulatory arrest was instituted and the recipient'sheart excised. The donor heart was transplanted in an orthotopic position.Before reinstitution of bypass, 250 ml of terminal leukocyte-depleted bloodcardioplegic solution was given, then bypass was restarted and the heartswere reperfused for 60 minutes. All animals were weaned from bypass withoutthe use of inotropic agents. All animals were extubated within 2 to 4 hoursafter bypass and received standard immunosuppression. Peak creatine kinaseMB/total creatine kinase ratio was 0.2% ± 0.2%. Postoperative ejectionfractions by echocardiography were 75% to 80% (mean 76%). Animals survived1, 9, 13, 16, and 34 days, with three deaths caused by acute rejection andone each by stroke and diarrhea/dehydration. Pathologic findings showed noareas of fibrosis or ischemic damage. We conclude that successful reanimationand engraftment can be achieved with the use of the asystolic primate heart;this work suggests that human application is realistic and could greatly expand thedonor pool. (J THORAC CARDIOVASC SURG 1995;109:1097-102)




This article has been cited by other articles:


Home page
NEJMHome page
M. M. Boucek, C. Mashburn, S. M. Dunn, R. Frizell, L. Edwards, B. Pietra, D. Campbell, and the Denver Children's Pediatric Heart Transplant T
Pediatric Heart Transplantation after Declaration of Cardiocirculatory Death
N. Engl. J. Med., August 14, 2008; 359(7): 709 - 714.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Kotani, K. Ishino, S. Osaki, O. Honjo, T. Suezawa, K. Kanki, C. Yutani, and S. Sano
Efficacy of MCI-186, a free-radical scavenger and antioxidant, for resuscitation of nonbeating donor hearts
J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1626 - 1632.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Osaki, K. Ishino, Y. Kotani, O. Honjo, T. Suezawa, K. Kanki, and S. Sano
Resuscitation of Non-Beating Donor Hearts Using Continuous Myocardial Perfusion: The Importance of Controlled Initial Reperfusion
Ann. Thorac. Surg., June 1, 2006; 81(6): 2167 - 2171.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
J. Martin, M. Krause, C. Benk, G. Lutter, M. Siegenthaler, and F. Beyersdorf
Blood cardioplegia filtration
Perfusion, January 1, 2003; 18(1_suppl): 75 - 80.
[Abstract] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Martin, K. Sarai, M. Yoshitake, J. Haberstroh, N. Takahashi, G. Lutter, and F. Beyersdorf
Orthotopic transplantation of pig hearts harvested after 30 min of normothermic ischemia: controlled reperfusion with blood cardioplegia containing the Na+-H+-exchange inhibitor HOE 642
Eur. J. Cardiothorac. Surg., December 1, 1998; 14(6): 607 - 614.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The American Association for Thoracic Surgery.